Position in ANVS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,860
-$370 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 61 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $53,387 across 28 Biotechnology names. ANVS ranks #11 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27 | $13,411 | |
| 2 | TLSA |
Tiziana Life Sciences Ltd
|
5,000 | $6,400 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6 | $3,741 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13 | $3,132 | |
| 5 | INCY |
Incyte Corp
|
25 | $2,834 | |
| 6 | EXEL |
Exelixis, Inc.
|
52 | $2,829 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8 | $2,408 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
67 | $2,371 |
All Filings in ANVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,860 | 1,000 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,230 | 1,000 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,460 | 1,000 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,070 | 1,000 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,170 | 1,000 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,500 | 1,000 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $5,030 | 1,000 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||